Sleep Bruxism, Pharmacotherapy, Sleep Aspects and Screen Use in Children and Adolescents With Down Syndrome: A
Sania Aparecida Miyagui1,2, Mariana Dos Santos Fernandes3, Lucas Fernandes Braga1
1Department of Pharmaceutical Sciences, Universidade Federal de São Paulo, Diadema, Brazil.
Background And Aims:
Bruxism is frequent in individuals with Down syndrome (DS), and there is a need to identify patient profiles to develop treatment plans that meet their specific needs.
Methods:
Cluster analysis was applied on clinical, dentofacial, sleep, pharmacotherapy, and screen use cross-sectional data from 101 children/adolescents with DS (5-18 years).
Results:
Cardiopathy and thyroid dysfunction were the most frequent health conditions. Centrally acting medications use increased with increasing age. Proxy-reported and clinically based sleep bruxism (SB) was found in 5% of children and 46% of adolescents. Three clusters were generated: 'children without SB', 'children/adolescents with lower frequency of SB', and 'adolescents with high frequency of SB'. SB, age, reflux, antidepressant use, snoring, sleep time, and smartphone/tablet use contributed most to cluster classification.
Conclusion:
The group of adolescents with high frequency of SB was characterized by antidepressant use, snoring, reflux, shorter sleep, and longer screen usage time.
Related Concept Videos
01:15REM Sleep Behavior Disorder
RBD is significantly associated with...
01:13Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...